Clinical Trial Update: Comparison of Sirolimus Alone With Sirolimus Plus Tacrolimus in Type 1 Diabetic Recipients of Cultured Islet Cell Grafts [NA]

View source ↗

Summary

A terminated clinical trial comparing sirolimus alone versus sirolimus plus tacrolimus in Type 1 diabetes patients receiving cultured islet cell grafts.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Islet Transplantation
• Type 1 Diabetes Mellitus

Drugs mentioned

• Sirolimus (Sirolimus)
• Tacrolimus (Tacrolimus)

Snippet

Sponsor: Universitair Ziekenhuis Brussel | Conditions: Islet Transplantation, Type 1 Diabetes | NA | Status: TERMINATED